SCHEMBL18817922

SCHEMBL18817922

C/C(=N\c1ccc(Cl)cc1)c1cc(Br)ccc1O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ PLAU P00749 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ CES2 O00748 1/20 0.43
▸ GALR3 O60755 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ NOS1 P29475 2/20 0.41
▸ CCR5 P51681 1/20 0.40
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ GSTA1 P08263 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18817925 1.00 LMNA (0.50) LMNASMN1; SMN2PLAUALDH1A1CES2
SCHEMBL18845626 0.86 MAOA (0.48) SMN1; SMN2PLAUCES2GALR3CYP1A2
SCHEMBL18817903 0.84 MAPT (0.47) PLAUCES2GALR3CYP1A2CYP2C9
SCHEMBL18817901 0.84 MAPT (0.47) PLAUCES2GALR3CYP1A2CYP2C9
SCHEMBL18817935 0.84 GSTA1 (0.47) SMN1; SMN2PLAUCES2GALR3CYP1A2
SCHEMBL18817938 0.84 GSTA1 (0.47) SMN1; SMN2PLAUCES2GALR3CYP1A2
SCHEMBL18817947 0.81 TMPRSS4 (0.46) LMNASMN1; SMN2PLAUALDH1A1CES2
SCHEMBL18817929 0.81 NOS1 (0.49) LMNASMN1; SMN2PLAUALDH1A1CES2
SCHEMBL18817944 0.81 TMPRSS4 (0.46) LMNASMN1; SMN2PLAUALDH1A1CES2
SCHEMBL18817930 0.81 NOS1 (0.49) LMNASMN1; SMN2PLAUALDH1A1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10155753-B2 4-substituted-2-(5-substituted-1H-indol-2-yl)phenol derivatives, methods for preparing the phenol derivatives and pharmaceutical compositions for inhibiting cell proliferation and migration including the phenol derivatives KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2018-12-18 — — US disclosed
US-20170129879-A1 4-SUBSTITUTED-2-(5-SUBSTITUTED-1H-INDOL-2-YL)PHENOL DERIVATIVES, METHODS FOR PREPARING THE PHENOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING CELL PROLIFERATION AND MIGRATION INCLUDING THE PHENOL DERIVATIVES KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10155753-B2 4-substituted-2-(5-substituted-1H-indol-2-yl)phenol derivatives, methods for preparing the phenol derivatives and pharmaceutical compositions for inhibiting cell proliferation and migration including the phenol derivatives MKI67, CCNI, CDK4 LMNA 2115/4885SMN1; SMN2 4029/4885PLAU 3570/4885
US-20170129879-A1 4-SUBSTITUTED-2-(5-SUBSTITUTED-1H-INDOL-2-YL)PHENOL DERIVATIVES, METHODS FOR PREPARING THE PHENOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING CELL PROLIFERATION AND MIGRATION INCLUDING THE PHENOL DERIVATIVES MKI67, CCNI, CDK4 LMNA 2115/4885SMN1; SMN2 4029/4885PLAU 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback